Standard Biotools (LAB) Operating Income (2010 - 2026)
Standard Biotools (LAB) posted quarterly Operating Income of -$12.5 million for Q1 2026, up 53.67% year-over-year from -$8.1 million in Q1 2025, and up 49.29% quarter-over-quarter from -$24.6 million in Q4 2025.
Standard Biotools (LAB) Operating Income (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Operating Income for 17 consecutive years, with -$12.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income rose 53.67% year-over-year to -$12.5 million; the TTM figure through Mar 2026 stood at -$95.8 million (up 12.94% YoY), while the FY2025 annual figure was -$110.2 million, up 13.52% from the prior year.
- Operating Income rose to -$12.5 million in Q1 2026 per LAB's latest filing, from -$24.6 million in the prior quarter.
- Across five years, Operating Income topped out at -$12.5 million in Q1 2026 and bottomed at -$60.2 million in Q1 2024.
- Historically, Operating Income has averaged -$27.0 million across 5 years, with a median of -$26.1 million in 2024.
- Annual changes were most pronounced in 2024 — Operating Income slumped 262.7% — and 2025, when it surged 55.19%.
- Standard Biotools' Operating Income stood at -$21.1 million in 2022, then slipped by 1.3% to -$21.4 million in 2023, then dropped by 21.96% to -$26.1 million in 2024, then advanced by 5.51% to -$24.6 million in 2025, then soared by 49.29% to -$12.5 million in 2026.
- Business Quant data shows LAB's Operating Income at -$12.5 million in Q1 2026, -$24.6 million in Q4 2025, and -$32.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn | -25.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.39 Mn |
| Mar 31, 2026 | -12.50 Mn |
| Dec 31, 2025 | -24.64 Mn |
| Sep 30, 2025 | -32.94 Mn |
| Jun 30, 2025 | -25.70 Mn |
| Mar 31, 2025 | -26.97 Mn |
| Dec 31, 2024 | -26.08 Mn |
| Sep 30, 2024 | -26.70 Mn |
| Jun 30, 2024 | -30.26 Mn |
| Mar 31, 2024 | -60.18 Mn |
| Dec 31, 2023 | -21.39 Mn |
| Sep 30, 2023 | -21.17 Mn |
| Jun 30, 2023 | -17.45 Mn |
| Mar 31, 2023 | -16.59 Mn |
| Dec 31, 2022 | -21.11 Mn |
| Sep 30, 2022 | -29.03 Mn |
| Jun 30, 2022 | -38.56 Mn |
| Mar 31, 2022 | -27.50 Mn |
| Sep 30, 2021 | -56.20 Mn |
| Jun 30, 2021 | -36.59 Mn |